Global Panic Disorders Market Global Report 2026 Market
Healthcare Services

Panic Disorders Industry Expansion Forecast Showing Market Size of $14.99 Billion by 2030 at 6.3% CAGR

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Panic Disorders Market From 2026 To 2030?

The panic disorders market has experienced robust expansion in recent years. Projections indicate it will increase from $11.15 billion in 2025 to $11.73 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 5.3%. The expansion observed during the historic period is linked to factors such as limited public understanding of panic disorders, a prevailing dependence on conventional in-person therapeutic approaches, expensive medication costs, a disjointed mental healthcare system, and minimal uptake of digital therapy instruments.

The panic disorders market is poised for robust expansion in the coming years. This market is projected to reach $15 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.3%. The anticipated growth during this period stems from factors such as the increasing occurrence of anxiety and panic disorders, a rise in telepsychiatry adoption, developments in virtual reality and neurofeedback treatments, the broadening of online pharmacy and hospital distribution networks, and a growing need for customized mental healthcare strategies. Key trends anticipated during the forecast period encompass an uptick in telepsychiatry and mobile mental health app usage, the incorporation of virtual reality therapy for anxiety conditions, wider application of biofeedback and neurofeedback methods, an increase in personalized medication protocols for panic disorders, and the expansion of mental healthcare centers and hospital provisions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13191&type=smp

What Major Drivers Are Influencing Demand In The Panic Disorders Market?

The expanding adoption of telehealth is projected to advance the growth of the panic disorders market. Telehealth leverages electronic communication technologies, such as videoconferencing, phone calls, and secure messaging, to offer remote healthcare services and medical consultations. It facilitates psychotherapy and counseling services for individuals with panic disorders, allowing therapists to conduct individual therapy, group therapy, or support groups via secure videoconferencing platforms. For instance, in April 2023, FAIR Health Inc., a US-based non-profit organization, observed a 7.3% national rise in telehealth usage, increasing from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Thus, the escalating utilization of telehealth is stimulating the growth of the panic disorders market.

Which Segments Are Included In The Analysis Of The Panic Disorders Market?

The panic disorders market covered in this report is segmented –

1) By Treatment Type: Pharmacotherapies, Psychotherapeutic Interventions, Digital Or Tech-Enabled Therapies

2) By Disorder Type: Panic Disorder Without Agoraphobia, Panic Disorder With Agoraphobia, Mild Panic Disorder, Moderate Panic Disorder, Severe Panic Disorder, Panic Disorder With Comorbidities

3) By Age Group: Children And Adolescents, Adults, Elderly

4) By End User: Hospitals, Specialty Mental Health Clinics, Primary Care Clinics, Telehealth And Digital Platforms, Home Healthcare Services

Subsegments:

1) By Pharmacotherapies: Antidepressants, Benzodiazepines, Beta-Blockers

2) By Psychotherapeutic Interventions: Cognitive Behavioral Therapy (CBT), Exposure Therapy, Psychodynamic Therapy, Group And Family Therapy

3) By Digital Or Tech-Enabled Therapies: Mental Health Apps, Telepsychiatry Or Teletherapy, Virtual CBT Programs

What Key Developments And Trends Are Impacting The Panic Disorders Market?

Leading companies in the panic disorder market are concentrating on creating innovative medications, such as extended-release capsules, to maintain their market standing. Extended-release capsules are a type of drug designed to gradually release their active component, usually over 12 or 24 hours, suitable for managing long-term conditions. An example is Granules India Ltd., an Indian pharmaceutical firm, which secured abbreviated new drug application (ANDA) approval for venlafaxine hydrochloride extended-release capsules from the US Food & Drug Administration (USFDA) in May 2023. This product showed bioequivalence with the reference-listed drug (RLD), Effexor XR Extended-Release Capsules, produced by Upjohn US 2 LLC. Venlafaxine HCl extended-release capsules are prescribed for the treatment of conditions such as generalized anxiety disorder (GAD), major depressive disorder (MDD), panic disorder (PD), and social anxiety disorder (SAD). Their mechanism involves elevating serotonin and norepinephrine levels in the brain, with an initial dosage typically set at 75 mg daily, adjustable by the physician as required.

Which Key Industry Participants Are Active In The Panic Disorders Market?

Major companies operating in the panic disorders market are F. Hoffmann-La Roche Ltd, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd, Mylan N.V., Pfizer Inc, Sun Pharmaceutical Industries Ltd, H. Lundbeck A/S, Neurocrine Biosciences Inc, Neuraxpharm, Actavis Plc, Sumitomo Pharma Co Ltd, LIFECARE NEURO PRODUCTS LTD, Merck & Co Inc, Johnson & Johnson, Novartis AG, Otsuka Pharmaceutical Co Ltd.

Read the full panic disorders market report here:

https://www.thebusinessresearchcompany.com/report/panic-disorders-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Panic Disorders Market?

North America was the largest region in the panic disorders market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panic disorders market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Panic Disorders Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13191&type=smp

Browse Through More Reports Similar to the Global Panic Disorders Market 2026, By The Business Research Company

Generalized Anxiety Disorder Global Market Report

https://www.thebusinessresearchcompany.com/report/generalized-anxiety-disorder-global-market-report

Migraine Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/migraine-treatment-global-market-report

Catalepsy Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/catalepsy-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model